The FY2025 (Dec) proxy of Dianthus Therapeutics, Inc. /DE/ names 19 peer companies for pay. Among Dianthus Therapeutics, Inc. /DE/ and these peers, CEO pay was the highest of 7 and total shareholder return was the highest of 7.
1st highest of 7in Dianthus Therapeutics, Inc. /DE/ and its pay peers, FY2025 (Dec) by CEO pay:
$6.1M$10.6M
1st highest of 7in Dianthus Therapeutics, Inc. /DE/ and its pay peers, FY2025 (Dec) by total shareholder return:
$17$652
Pay peer group, FY2025 (Dec) proxy
| Disc Medicine | ||
| Kymera Therapeutics | ||
| Structure Therapeutics | ||
| Vera Therapeutics | ||
| Spyre Therapeutics | ||
| Anaptysbio | ||
| 4D Molecular Therapeutics, Inc. | Not disclosed | Not disclosed |
| Annexon, Inc. | Not disclosed | Not disclosed |
| Apogee Therapeutics, Inc. | Not disclosed | Not disclosed |
| Astria Therapeutics, Inc. | Not disclosed | Not disclosed |
| Aura Biosciences | Not disclosed | Not disclosed |
| Cabaletta Bio, Inc. | Not disclosed | Not disclosed |
| Dyne Therapeutics | Not disclosed | Not disclosed |
| Edgewise Therapeutics | Not disclosed | Not disclosed |
| Inozyme Pharma, Inc. | Not disclosed | Not disclosed |
| Kyverna Therapeutics, Inc. | Not disclosed | Not disclosed |
| Longboard Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Pepgen Inc. | Not disclosed | Not disclosed |
| Stoke Therapeutics | Not disclosed | Not disclosed |
19 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.